Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2949 of 5804
-
Experimental lymphoma drug DS-3201b enters early human testing
Disease control OngoingDS-3201b is an experimental drug that is being investigated in clinical research. Adults with non-Hodgkin lymphoma (NHL) may be able to join this study if their disease has come back after remission or is not responding to current treatment This study has three parts. The Dose …
Phase: PHASE1 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New MRI technique could sharply improve prostate cancer detection
Diagnosis Recruiting nowThis pilot clinical trial studies how well magnetic resonance spectroscopic imaging (MRSI) with hyperpolarized carbon 13 (13C) pyruvate alone or in combination with 13C 15N2 Urea works in finding prostate cancer that exhibits poorly differentiated or undifferentiated cells (high-…
Phase: EARLY_PHASE1 • Sponsor: Ivan de Kouchkovsky, MD • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New ultrasound technique may sharpen lung cancer staging
Diagnosis CompletedThis clinical trial studies how well endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) after positron emission tomography/computed tomography (PET/CT) scan works in diagnosing patients with stage I-IIA non-small cell lung cancer evaluated for stereotact…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New drug OMS721 tested for rare kidney conditions
Disease control TerminatedThe purpose of this study was to evaluate the safety and tolerability of OMS721 (narsoplimab) in participants with Immunoglobulin A Nephropathy (IgAN), Lupus Nephritis (LN), Membranous Nephropathy (MN), and Complement Component 3 Glomerulopathy (C3G) including Dense Deposit Disea…
Phase: PHASE2 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug MN-001 tested for scarred lungs in tiny trial
Disease control CompletedThis is a randomized, placebo-controlled, double-blind, 6-month study followed by a 6-month open-label extension phase to evaluate the efficacy, safety, and tolerability of MN-001 in patients diagnosed with moderate to severe idiopathic pulmonary fibrosis (IPF). Participants were…
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Scientists decode gait signatures to spot brain diseases
Knowledge-focused OngoingThe purpose of this study is to investigate whether speed-dependent measures of gait (so called gait signatures) can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Green tea extract may sharpen minds of kids with fetal alcohol syndrome
Symptom relief CompletedThe flavonoid epigallocatechin gallate (EGCG) is a modulator of neuronal plasticity useful in other neurodevelopmental diseases. A recent study showed that EGCG is a promising tool for cognitive and health related quality of life improvement in Down's syndrome. The objective is …
Phase: NA • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a walk and a chat beat anxiety in seniors?
Symptom relief OngoingGeneralised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of other severe conditions such as depression and dementia, and effective treatments …
Phase: NA • Sponsor: Solli Distriktspsykiatriske Senter • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Keto diet for epilepsy: heart risks under the microscope
Disease control OngoingThis research is being done to evaluate the short term and long term effects of ketogenic diets on measures of cardiovascular health. Such measures include cholesterol levels, blood pressure, weight, and thickening of the blood vessel wall over time. Adults aged 18 or older who a…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental hepatitis b drug combo shows promise but study halted early
Disease control TerminatedChronic HBV patients will receive 9 doses of open-label ARC-520 once every 4 weeks and be evaluated for safety and efficacy.
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
HIV remission safety check: what happens when treatment stops?
Knowledge-focused Recruiting nowThis exploratory study is designed to ensure the safety of HIV-infected volunteers who complete research protocols that include an analytic treatment interruption (ATI). This is a prospective cohort study of volunteers who were diagnosed with HIV during early acute HIV infection,…
Sponsor: SEARCH Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Hypnosis may calm nerves during heart procedure, study finds
Symptom relief CompletedThe purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs.
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Fewer radiation sessions before sarcoma surgery shows promise in early trial
Disease control CompletedThis is a nonrandomized Phase II pilot protocol to determine the feasibility, toxicity and disease control (local control, overall and progression-free survival) using hypofractionated preoperative radiation therapy in patients with primary localized soft tissue sarcomas (STS).
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Experimental drug roscovitine tested in cystic fibrosis patients
Disease control TerminatedThis is a phase II, dose ranging, multicenter, randomized, double-blind, placebo-controlled study. The aim of this study is to assess the safety of increasing doses of roscovitine administered orally for 4 cycles of 4 consecutive days (treatment "on") separated by a 3 days treat…
Phase: PHASE2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New ultrasound technique may predict chemo response in breast cancer
Diagnosis CompletedAssess the accuracy of the sequential measurements by 3D Shear Wave Elastography (SWE) for predicting histological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New eye scan may spot glaucoma before vision loss begins
Diagnosis CompletedGlaucoma is the first cause of irreversible blindness worldwide with more than 60 millions people affected in 2010. It is defined as a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells (RGC), visual field deterioration and optic nerve excavat…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows early promise for hard-to-treat colorectal cancer
Disease control CompletedThis study is being done to test the safety and effectiveness of the combination of intravenous (IV) romidepsin and/or oral 5-azacitidine with IV MK-3475 in people with microsatellite stable (MSS) advanced colorectal cancer.
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Psoriatic arthritis drug apremilast tracked for two years in Real-World study
Disease control CompletedA total of approximately 500 patients with active psoriatic arthritis in an estimated 80 to 100 trial centers are to be enrolled. Selection of centers will be made by the sponsor's medical section. To increase the quality of the data and to reduce distribution of the data collect…
Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Virtual reality test reveals hidden memory damage in cured Cushing's patients
Knowledge-focused CompletedCushing's disease is a state of chronic endogenous glucocorticoid excess. Cushing's disease is responsible for increased morbidity and mortality. Recent studies have pinpointed the frequency of somatic sequelas and persistent alteration in quality of life despite the cure of the …
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New ointment shows promise for stubborn hand eczema
Symptom relief CompletedTo compare the efficacy of twice daily applications of LEO 124249 ointment with LEO 124249 ointment vehicle for up to 8 weeks in the treatment of subjects with chronic hand eczema.
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC